Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone

Physiology and Behavior

Volumn 93, Issue 4-5, 2008, Pages 1005-1010

  Zalewska Kaszubska, Jadwiga ^a   Gorska, Dorota ^a   Dyr, Wanda ^b   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Alcohol preferring rats; Beta endorphin; Ethanol; Free choice procedure; Naltrexone

Indexed keywords

ALCOHOL; BETA ENDORPHIN; NALTREXONE;

ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLUID INTAKE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 40749137298     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.01.007     Document Type: Article

References (46)

1. Bienkowski P., Kostowski W., and Koros E. Ethanol-reinforced behaviour the rat: effects of naltrexone. Eur J Pharmacol 374 (1999) 321-327
2. Cichelli M.J., and Lewis M.J. Naloxone nonselective suppression of drinking of ethanol, sucrose saccharin and water by rats. Pharmacol Biochem Behav 72 (2002) 699-706
3. Coonfield D.L., Hill K.G., Kaczmarek H.J., Ferraro III F.M., and Kiefer S.W. Low doses of naltrexone reduce palability and consumption of ethanol in outbred rats. Alcohol 26 (2002) 43-47
4. Coonfield D.L., Kiefer S.W., Ferraro III F.M., and Sinclair J.D. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone. Behav Neurosci 118 (2004) 1089-1096
5. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., and Kreek M.J. Naltrexone decreases craving and alcohol self-administration in alcohol dependent subjects and activates the hypothalamic-pituitary adrenocortical axis. Psychopharmacology 160 (2002) 19-29
6. Stromberg M.F. The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat. Pharmacol Biochem Behav 78 (2004) 743-750
7. Okulicz-Kozaryn I., Mikołajczak P., Kamińska E., Kamińska I., Szulc M., and Borkiewicz-Kozlowska T. Effect of naltrexone administration on short-term memory in chronically ethanol-treated outbred rats. Alcohol Alcohol 39 (2004) 14-19
8. Kranzler H.R., Armeli S., Tennen H., Blomqvist O., Oncken C., Petry N., et al. Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 23 (2003) 294-304
9. Killeen T.K., Brady K.T., Gold P.B., Simpson K.N., Faldowski R.A., Tyson C., et al. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res 28 (2004) 1710-1717
10. Gonzales R.A., and Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18 (1998) 10663-10671
11. Rodefer J.S., Campbell U.C., Cosgrove K.P., and Carroll M.E. Naltrexone pre-treatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food under concurrent progressive-ratio schedules in rhesus monkeys. Psychopharmacology (Berl) 141 (1999) 436-446
12. Ferraro III F.M., Hill K.G., Kaczmarek H.J., Coonfield D.L., and Kiefer S.W. Naltrexone modifies the palatability of basic tastes and alcohol in outbred male rats. Alcohol 27 (2002) 107-114
13. Hill K.G., and Kiefer S.W. Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcohol Clin Exp Res 21 (1997) 637-641
14. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 26 (2001) 308-314
15. Zalewska-Kaszubska J., and Czarnecka E. Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides 26 (2005) 701-705
16. Koob G.F., Roberts A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytia P., et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22 (1998) 3-9
17. Koob G.F., Rassnick S., Heinrichs S., and Weiss F. Alcohol, the reward system and dependence. EXS 71 (1994) 103-114
18. Froehlich J.C. The neurobiology of ethanol-opioid interaction in ethanol reinforcement. Alcohol Clin Exp Res 20 8 Suppl (1996) 181A-186A
19. Di Chiara G. Alcohol and dopamine. Alcohol Health Res World 21 (1997) 108-114
20. Rasmussen D.D., Bryant C.A., Boldt B.M., Colasurdo B.A., Levin N., and Wilkinson C.W. Acute alcohol effects on opiomelanocortinergic regulation. Alcohol Clin Exp Res 22 (1998) 789-801
21. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine and amphetamine. J Neurosci 21 RC184 (2001) 1-5
22. Marinelli P.W., Quirion R., and Gianoulakis C. A microdialysis profile of β-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology 169 (2003) 60-67
23. Marinelli P.W., Quirion R., and Gianoulakis C. Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins. Behav Brain Res 139 (2003) 59-67
24. Marinelli P.W., Quirion R., and Gianoulakis C. An in vivo profile of β-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience 127 (2004) 777-784
25. Genazzani A.R., Nappi G., Facchinetti F., Mazzolla G.L., Parrini D., Sinforiani E., et al. Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab 55 (1982) 583-586
26. Zalewska-Kaszubska J., Gorska D., Dyr W., and Czarnecka E. Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone. Pharmacol Biochem Behav 85 (2006) 155-159
27. Dyr W., and Kostowski W. Preliminary phenotypic characterization of Warsaw high preferring (WHP) and Warsaw low preferring (WLP) lines of rats selectively bred for high and low ethanol consumption. Pol J Pharmacol 56 (2004) 359-365
28. Zalewska-Kaszubska J., Cwiek W., Dyr W., and Czarnecka E. Changes in the beta endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference. Neurosci Lett 388 (2005) 45-48
29. Zalewska-Kaszubska J., Gorska D., Dyr W., and Czarnecka E. Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference. Prog Neuro-Psychopharmacol Biol Psychiatry 31 (2007) 525-528
30. Rezvani A.H., Overstreet D.H., Mason G.A., Janowsky D.S., Hamedi M., Clark Jr. E., et al. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol 35 (2000) 76-83
31. Angwin P., and Barchas J.D. Use of silicic acid extraction and reversed-phase columns for rapid purification prior to radioimmunoassay. J Chromatogr 231 (1982) 173-177
32. Zalewska-Kaszubska J., and Obzejta D. Use of low-energy laser as adjunct treatment of alcohol addiction. Lasers Med Sci 19 (2004) 100-104
33. Kornet M., Goosen C., and Van Ree J.M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology (Berl) 104 (1991) 367-376
34. 3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake. Eur J Pharmacol 491 (2004) 149-156
35. Davidson D., and Amit Z. Naltrexone block acquisition of voluntary ethanol intake in rats. Alcohol Clin Exp Res 21 (1997) 677-683
36. Sandi C., Borrell J., and Guaza C. Naloxone decreases ethanol consumption within a free choice paradigm in rats. Pharmacol Biochem Behav 29 (1988) 39-43
37. Davidson D., and Amit Z. Effects of naloxone on limited-access ethanol drinking in rats. Alcohol Clin Exp Res 20 (1996) 664-669
38. Cowen M.S., and Lawrence A.J. Alterations in central proenkephalin mRNA expression after chronic free-choice ethanol consumption by fawn-hooded rats. Alcohol Clin Exp Res 25 (2001) 1126-1133
39. Gianoulakis C., Beliveau D., Angelogianni P., Meaney M., Thavundayil J., Tawar V., et al. Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 45 (1989) 1097-1109
40. Dai X., Thavundayil J., and Gianoulakis C. Differences in the responses of the pituitary beta-endorphin and cardiovascular system to ethanol and stress as a function of family history. Alcohol Clin Exp Res 26 (2002) 1171-1180
41. Juarez J., and Eliana Bde T. Alcohol consumption is enhanced after naltrexone treatment. Alcohol Clin Exp Res 31 (2007) 260-264
42. Cowen M.S., Rezvani A.H., Jarrott B., and Lawrence A.J. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in μ-opioid receptor density. Alcohol Clin Exp Res 23 (1999) 1008-1014
43. Lesscher H.M., Bailey A., Burbach J.P., Van Ree J.M., Kitchen I., and Gerrits M.A. Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. Eur J Neurosci 17 (2003) 1006-1012
44. Gullapalli S., and Ramarao P. Regulation of dihydropyridine-sensitive Ca(2+) channels during naloxone-induced opioid supersensitivity in rats. Eur J Pharmacol 45 (2002) 271-277
45. Lee S.C., and Yoburn B.C. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity. Pharmacol Biochem Behav 66 (2000) 347-351
46. Dai X., Thavundayil J., and Gianoulakis C. Differences in the peripheral levels of β-endorphin in response to alcohol and stress as function of alcohol dependence and family history of alcoholism. Alcohol Clin Exp Res 29 (2005) 1965-1975